Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2000. Start Trial.
Date Value
October 05, 2026 0.789
October 02, 2026 0.8034
October 01, 2026 0.8307
September 30, 2026 0.839
September 29, 2026 0.829
September 28, 2026 0.8314
September 25, 2026 0.8299
September 24, 2026 0.8793
September 23, 2026 0.9519
September 22, 2026 1.00
September 21, 2026 0.9746
September 18, 2026 1.00
September 17, 2026 1.09
September 16, 2026 1.12
September 15, 2026 1.13
September 14, 2026 1.12
September 11, 2026 1.13
September 10, 2026 1.16
September 09, 2026 1.20
September 08, 2026 1.27
September 04, 2026 1.35
September 03, 2026 1.37
September 02, 2026 1.38
September 01, 2026 1.42
August 31, 2026 1.49
Date Value
August 28, 2026 1.49
August 27, 2026 1.50
August 26, 2026 1.54
August 25, 2026 1.59
August 24, 2026 1.58
August 21, 2026 1.58
August 20, 2026 1.61
August 19, 2026 1.72
August 18, 2026 1.70
August 17, 2026 1.80
August 14, 2026 1.80
August 13, 2026 1.87
August 12, 2026 1.67
August 11, 2026 2.31
August 10, 2026 3.66
August 07, 2026 4.02
August 06, 2026 4.41
August 05, 2026 4.545
August 04, 2026 4.72
August 03, 2026 5.15
July 31, 2026 5.02
July 30, 2026 4.96
July 29, 2026 4.98
July 28, 2026 4.83
July 27, 2026 4.69

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Agenus, Inc. 8.73
Amgen, Inc. 603.43
BioCryst Pharmaceuticals, Inc. 8.10
Imunon, Inc. 1.24
CEL-SCI Corp. 2.42